NCT04965142

Brief Summary

Post-transplant metabolic syndrome (PTMS) affects about 50% liver transplant (OLT) and 25% lung transplant (LTx) recipients at 12-18 months post-transplant. PTMS (comprised of glucose intolerance, obesity, hypercholesterolemia and hypertension) has been associated with increased risk for cardiovascular morbidity and long-term survival. Exercise studies in the early post-transplant period have shown some benefits on PTMS risk factors with facility-based training, but it remains unclear if exercise can be sustained in the home environment with sufficient adherence or training intensity to impact PTMS beyond the early post-transplant period. Objectives: 1) To evaluate the feasibility of a three-month individualized, virtual home-based exercise training program in OLT and LTx recipients starting at 1 year post-transplant. 2) To assess estimates of intervention efficacy on elements of PTMS, insulin resistance, exercise self-efficacy, and health related quality of life (HRQL). Methods: 20 OLT and 20 LTx recipients with 2 or more PTMS risk factors at 12-18 months post-transplant will be randomized to a home-based exercise program versus usual care. The exercise group will undergo aerobic training 3 to 5 times per week with resistance training at least twice weekly over a 12-week period. Exercises will be demonstrated by a qualified exercise professional during the first visit with weekly phone and video calls to guide exercise progression, ease communication and promote exercise self-efficacy and adherence based on guiding behavioral principles. As secondary measures, PTMS, insulin resistance, body composition (optional), HRQL, and assessment of self-efficacy will be assessed at baseline and 12-weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2021

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 16, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

August 19, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2024

Completed
Last Updated

November 26, 2024

Status Verified

November 1, 2024

Enrollment Period

2.8 years

First QC Date

June 17, 2021

Last Update Submit

November 22, 2024

Conditions

Keywords

Lung Transplant RecipientsLiver Transplant RecipientsExercise Training

Outcome Measures

Primary Outcomes (6)

  • Recruitment

    We will measure recruitment-success percentage and will record reasons for non-participation.

    When recruitment is complete (approximately 18 months after study initiation)

  • Adherence to Exercise Training

    Adherence to the home-based exercise program (aerobic and resistance) will be measured through an exercise diary completed by participants and reviewed through weekly communication.

    Over a 12 week period

  • Study Retention

    Retention will be assessed by measuring attrition throughout the intervention period.

    Over a 12 week period

  • Adverse Events During Exercise Training (Safety and Tolerability)

    Adverse events with exercise training will be assessed throughout the study period.

    Over a 12 week period

  • Participant Satisfaction with Exercise Training and Study Participation (Exercise Group)

    Multiple choice and free form questionnaire assessing the participants' satisfaction with the home exercise program and study intervention.

    Change over the study period assessed at weeks 2, 6, and 12

  • Participant Satisfaction with Study Participation (Control Group)

    Multiple choice and free form questionnaire assessing participants' satisfaction with the study intervention.

    12 weeks from baseline assessment

Secondary Outcomes (16)

  • Total Cholesterol

    Change from baseline at 12 weeks

  • Triglycerides

    Change from baseline at 12 weeks

  • High Density Lipoprotein

    Change from baseline at 12 weeks

  • Low Density Lipoprotein

    Change from baseline at 12 weeks

  • Fasting Blood Glucose Levels

    Change from baseline at 12 weeks

  • +11 more secondary outcomes

Other Outcomes (4)

  • Liver Fibrosis

    Change from baseline at 12 weeks

  • Fat Free Mass Index

    Change from baseline at 12 weeks

  • Body Fat Mass Index

    Change from baseline at 12 weeks

  • +1 more other outcomes

Study Arms (2)

Home Exercise Group

EXPERIMENTAL

The home-based exercise group will be asked to exercise 3 to 5 times per week (≥ 150 minutes of aerobic exercises (i.e. walking, cycling, or treadmill) of at least moderate intensity) and to also complete resistance training (resistance bands or free weights) at least twice weekly over a 12-week period supervised by an exercise professional. The resistance training will be personalized, aiming for 6 to 10 exercises targeting the major muscle groups, progressing to 3 sets of 8 to 12 repetitions. Exercise prescriptions will be developed and monitored by an exercise professional with weekly follow-up meetings and supported with a web application (Physiotec) that allows customizable exercise prescriptions, tracking of exercise completion, and video tutorials. Participants will receive one counselling session on healthy eating and physical activity at the start of the study along with an exercise manual.

Behavioral: Exercise Training

Control Group

NO INTERVENTION

Participants will receive one counselling session on healthy eating and physical activity at the start of the study.

Interventions

The intervention group will be asked to complete aerobic exercises 3 to 5 times per week (≥ 150 minutes of at least moderate aerobic intensity) and resistance training at least twice a week over a 12-week period.

Home Exercise Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult lung and liver transplant recipients 12 to 18 months post-transplant
  • Presence of 2 or more metabolic risk factors (hypertension, hyperlipidemia, diabetes, obesity)

You may not qualify if:

  • Active cardiovascular disease (recent heart attack, significant coronary artery disease on cardiac catheterization, heart failure, uncontrolled arrhythmias, chest pain, dizziness, or fainting in the last 3 months)
  • Neuro-muscular disease or orthopedic limitations
  • Physically active with ≥ 150 minutes/week of moderate-intensity aerobic physical activity
  • Residing outside the province of Ontario

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Health Network - Toronto General Hospital

Toronto, Ontario, M5G 2C4, Canada

Location

Related Publications (1)

  • Rozenberg D, Santa Mina D, Nourouzpour S, Camacho Perez E, Stewart BL, Wickerson L, Tsien C, Selzner N, Shore J, Aversa M, Woo M, Holdsworth S, Prevost K, Park J, Azhie A, Huszti E, McLeod E, Dales S, Bhat M. Feasibility of a Home-Based Exercise Program for Managing Posttransplant Metabolic Syndrome in Lung and Liver Transplant Recipients: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2022 Mar 23;11(3):e35700. doi: 10.2196/35700.

MeSH Terms

Conditions

Metabolic Syndrome

Interventions

Exercise

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Dmitry Rozenberg, MD PhD

    University Health Network /University of Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Lung and liver transplant recipients will be randomized to home exercise group versus usual care group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 17, 2021

First Posted

July 16, 2021

Study Start

August 19, 2021

Primary Completion

May 30, 2024

Study Completion

July 30, 2024

Last Updated

November 26, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations